Long-term follow-up of patients with recessive dystrophic epidermolysis bullosa in the Netherlands: expansion of the mutation database and unusual phenotype-genotype correlations
- PMID: 19665875
- DOI: 10.1016/j.jdermsci.2009.06.015
Long-term follow-up of patients with recessive dystrophic epidermolysis bullosa in the Netherlands: expansion of the mutation database and unusual phenotype-genotype correlations
Abstract
Background: The current classification of recessive dystrophic epidermolysis bullosa (RDEB) comprises two major subtypes: 'severe generalized RDEB' (RDEB-sev gen) with early-onset, extensive, generalized blistering and scarring, complete absence of type VII collagen, and bi-allelic COL7A1 null mutations; milder 'generalized other RDEB' (RDEB-O) with reduced-to-normal type VII collagen expression, and non-null genotypes.
Objective: To search for previously unrecognized phenotype-genotype correlations in 33 Dutch RDEB families.
Methods: We analyzed extensive clinical follow-up data, available for all patients up to 19 years, detailed type VII collagen immunostaining and genotypes, and correlated clinical phenotype to molecular phenotype and genotype.
Results: We identified 20 novel COL7A1 mutations. In 14 of 15 RDEB-sev gen patients type VII collagen was completely absent, one had strongly reduced type VII collagen, and all carried bi-allelic null mutations. Five of 11 RDEB-O patients developed pseudosyndactyly of the fingers preceded by skin atrophy and flexion contractures later in childhood and adolescence. All five had esophageal involvement and growth retardation. Type VII collagen immunostaining ranged from strongly reduced to slightly reduced in RDEB-O patients with pseudosyndactyly, whereas RDEB-O patients without pseudosyndactyly had slightly reduced to normal type VII collagen staining. There was no difference in genotypes between both groups, although we unexpectedly found bi-allelic null mutations in two of five RDEB-O patients with pseudosyndactyly.
Conclusion: Pseudosyndactyly occurs in approximately half of RDEB-O patients when type VII collagen is strongly reduced. The prognosis in RDEB cannot always be simply predicted from the COL7A1 genotype.
Similar articles
-
Dystrophic epidermolysis bullosa phenotypes in a large consanguineous Tunisian family.J Dermatol Sci. 2009 May;54(2):114-20. doi: 10.1016/j.jdermsci.2009.01.006. Epub 2009 Mar 3. J Dermatol Sci. 2009. PMID: 19261445
-
Review of collagen VII sequence variants found in Australasian patients with dystrophic epidermolysis bullosa reveals nine novel COL7A1 variants.J Dermatol Sci. 2007 Jun;46(3):169-78. doi: 10.1016/j.jdermsci.2007.02.006. Epub 2007 Apr 10. J Dermatol Sci. 2007. PMID: 17425959 Review.
-
Genotype-phenotype correlations in six Japanese patients with recessive dystrophic epidermolysis bullosa with the recurrent p.Glu2857X mutation.J Dermatol Sci. 2008 Oct;52(1):13-20. doi: 10.1016/j.jdermsci.2008.03.005. Epub 2008 Apr 25. J Dermatol Sci. 2008. PMID: 18440202
-
Does the position of the premature termination codon in COL7A1 correlate with the clinical severity in recessive dystrophic epidermolysis bullosa?Exp Dermatol. 2004 Apr;13(4):229-33. doi: 10.1111/j.0906-6705.2004.00167.x. Exp Dermatol. 2004. PMID: 15086338
-
Mutation analysis and characterization of COL7A1 mutations in dystrophic epidermolysis bullosa.Exp Dermatol. 2008 Jul;17(7):553-68. doi: 10.1111/j.1600-0625.2008.00723.x. Exp Dermatol. 2008. PMID: 18558993 Review.
Cited by
-
Dystrophic epidermolysis with dilation of esophageal stricture: A case report.Exp Ther Med. 2023 Dec 28;27(2):79. doi: 10.3892/etm.2023.12367. eCollection 2024 Feb. Exp Ther Med. 2023. PMID: 38264431 Free PMC article.
-
Case report: bullous pemphigoid development underlies dystrophic epidermolysis bullosa disease worsening.Front Immunol. 2022 Jul 29;13:929286. doi: 10.3389/fimmu.2022.929286. eCollection 2022. Front Immunol. 2022. PMID: 35967298 Free PMC article.
-
Prevalence of anemia in patients with epidermolysis bullosa registered in Australia.Int J Womens Dermatol. 2015 Feb 18;1(1):37-40. doi: 10.1016/j.ijwd.2014.12.001. eCollection 2015 Feb. Int J Womens Dermatol. 2015. PMID: 28491953 Free PMC article.
-
Clinical and allelic heterogeneity in dystrophic epidermolysis bullosa- lessons from an Indian cohort.PLoS One. 2023 Aug 9;18(8):e0289558. doi: 10.1371/journal.pone.0289558. eCollection 2023. PLoS One. 2023. PMID: 37556444 Free PMC article.
-
Natural Exon Skipping Sets the Stage for Exon Skipping as Therapy for Dystrophic Epidermolysis Bullosa.Mol Ther Nucleic Acids. 2019 Dec 6;18:465-475. doi: 10.1016/j.omtn.2019.09.009. Epub 2019 Sep 19. Mol Ther Nucleic Acids. 2019. PMID: 31670143 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources